GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Gaush Meditech Ltd (HKSE:02407) » Definitions » EV-to-Revenue

Gaush Meditech (HKSE:02407) EV-to-Revenue : 3.16 (As of Jun. 03, 2024)


View and export this data going back to 2022. Start your Free Trial

What is Gaush Meditech EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Gaush Meditech's enterprise value is HK$2,383.7 Mil. Gaush Meditech's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was HK$754.8 Mil. Therefore, Gaush Meditech's EV-to-Revenue for today is 3.16.

The historical rank and industry rank for Gaush Meditech's EV-to-Revenue or its related term are showing as below:

HKSE:02407' s EV-to-Revenue Range Over the Past 10 Years
Min: 1.53   Med: 2.86   Max: 3.64
Current: 3.16

During the past 5 years, the highest EV-to-Revenue of Gaush Meditech was 3.64. The lowest was 1.53. And the median was 2.86.

HKSE:02407's EV-to-Revenue is ranked better than
50.66% of 829 companies
in the Medical Devices & Instruments industry
Industry Median: 3.19 vs HKSE:02407: 3.16

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-06-03), Gaush Meditech's stock price is HK$16.32. Gaush Meditech's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was HK$5.10. Therefore, Gaush Meditech's PS Ratio for today is 3.20.


Gaush Meditech EV-to-Revenue Historical Data

The historical data trend for Gaush Meditech's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gaush Meditech EV-to-Revenue Chart

Gaush Meditech Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-Revenue
- - - 5.41 3.53

Gaush Meditech Semi-Annual Data
Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
EV-to-Revenue Get a 7-Day Free Trial - - 5.41 - 3.53

Competitive Comparison of Gaush Meditech's EV-to-Revenue

For the Medical Devices subindustry, Gaush Meditech's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Gaush Meditech's EV-to-Revenue Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Gaush Meditech's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Gaush Meditech's EV-to-Revenue falls into.



Gaush Meditech EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Gaush Meditech's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=2383.684/754.8
=3.16

Gaush Meditech's current Enterprise Value is HK$2,383.7 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Gaush Meditech's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was HK$754.8 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Gaush Meditech  (HKSE:02407) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Gaush Meditech's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=16.32/5.102
=3.20

Gaush Meditech's share price for today is HK$16.32.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. {COMPANY->company}'s Revenue per Sharefor the trailing twelve months (TTM) ended in Dec. 2023 was HK$5.10.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Gaush Meditech EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Gaush Meditech's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Gaush Meditech (HKSE:02407) Business Description

Traded in Other Exchanges
Address
No.11 Dongzhimen South Avenue, Room 1901, Building A, Zhonghui Plaza, Dongcheng District, Beijing, CHN
Gaush Meditech Ltd is a provider of a broad spectrum of ophthalmic medical devices. The segments of the company include 1) Proprietary products segment develops and produces surgical equipment and related supporting software, intra-optical lens, ophthalmic disease diagnosis and treatment equipment and related supporting consumables independently; 2) Distribution products segment sells multi-function diagnostic equipment, ocular fundus diagnosis, surgical and treatment equipment and related supporting consumables produced by ophthalmic medical equipment manufacturers; 3) Technical services segment provides warranty services, maintenance services and after-sales services related consumables; and 4) Others segment.
Executives
Orbimed Advisors Iii Limited 2102 Investment manager
Orbimed Asia Gp Iii, L.p. 2102 Investment manager
Orbimed Asia Partners Iii, L.p. 2102 Investment manager
Gao Tieta 2201 Interest of corporation controlled by you
Gaush Holding Ltd 2101 Beneficial owner
Cuprite Gem Investments Ltd 2101 Beneficial owner
Warburg Pincus (bermuda) Private Equity Gp Ltd. 2201 Interest of corporation controlled by you
Warburg Pincus (cayman) China-southeast Asia Ii Gp Llc 2201 Interest of corporation controlled by you
Warburg Pincus (cayman) China-southeast Asia Ii Gp, L.p. 2201 Interest of corporation controlled by you
Warburg Pincus China-southeast Asia Ii (cayman), L.p. 2201 Interest of corporation controlled by you
Warburg Pincus Partners Ii (cayman), L.p. 2201 Interest of corporation controlled by you

Gaush Meditech (HKSE:02407) Headlines

No Headlines